Filana Therapeutics, Inc. (FLNA)
NASDAQ: FLNA · Real-Time Price · USD
0.4421
-0.0089 (-1.97%)
Nov 6, 2026, 10:42 AM EST - Market open
Filana Therapeutics Employees
As of December 31, 2025, Filana Therapeutics had 20 total employees, including 17 full-time and 3 part-time employees. The number of employees decreased by 10 or 33.33% compared to the previous year. That makes Filana Therapeutics the 38,317th largest employer in the world and 5,512th in the United States.
Employees
20
Change (1Y)
-10
Growth (1Y)
-33.33%
Revenue / Employee
n/a
Profits / Employee
-$2,114,000
Market Cap
21.36M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 20 | -10 | -33.33% | 17 | 3 |
| Dec 31, 2024 | 30 | 1 | 3.45% | 30 | 0 |
| Dec 31, 2023 | 29 | 3 | 11.54% | 29 | 0 |
| Dec 31, 2022 | 26 | 2 | 8.33% | 26 | 0 |
| Dec 31, 2021 | 24 | 13 | 118.18% | 24 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 115 |
| Metagenomi Therapeutics | 113 |
| Aligos Therapeutics | 82 |
| BeyondSpring | 44 |
| NextCure | 40 |
| Aardvark Therapeutics | 28 |
| Edesa Biotech | 17 |
| TransCode Therapeutics | 12 |
FLNA News
- 1 day ago - Filana Therapeutics Earnings release: Q3 2026 - Filings
- 1 day ago - Filana Therapeutics Quarterly report: Q3 2026 - Filings
- 9 days ago - Filana Therapeutics Announces Publication in Cells of Promising Preclinical Findings for Simufilam in TSC2-Deficient Cells - GlobeNewsWire
- 4 weeks ago - Filana Therapeutics to Participate in the 2026 Maxim Growth Summit - GlobeNewsWire
- 6 weeks ago - Filana can proceed with study as hold lifted, says Lucid Capital - TheFly
- 6 weeks ago - Filana Therapeutics announces U.S. FDA lifted clinical hold on simufilam - TheFly
- 6 weeks ago - Filana Therapeutics Announces FDA Lift of Clinical Hold on Simufilam, Enabling Phase 2a Study in TSC-Related Epilepsy - GlobeNewsWire
- 2 months ago - Did Filana Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PRNewsWire